Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LAHO Pfizer.. Allergan Merge..$160 Billion Deal.. New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
5000 cases, 2 Clinical trials, 37 clinics GLOBAL!
Patients Treatment +2000
Improvement and satisfaction 95%
Medical cases done 5000
http://cellgenic.com/our-story/#
http://cellgenic.com/articles/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150429125
Harvard Stem Cell
..Our mission is to find cures for human diseases.
https://hsci.harvard.edu/
YALE
The potential impact of stem cell research on human health is enormous.[/color]
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
YALE
Stem cells..jacks of all trades. alleviating..heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
OXFORD
a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.
https://www.stemcells.ox.ac.uk/home
upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
Stem..Market.Growth..Due to.. increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
$LAHO $600B market..20M shares @.05 $1M!..Conservative measure.
$LAHO Thanks again for your support!
Stay tuned to our upcoming certifications!
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, it’s valued at a staggering $12 billion. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
global stem cell therapy..average growth rate of 46.81%
Stem Cell Therapy Market Segment by Applications, can be divided into:
Musculoskeletal Disorder
Wounds and Injuries
Cornea
Cardiovascular Diseases
Others
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
$LAHO Massive upside awaits given Nasdaq top Stem rev-price-opportunity ratio$$
$LAHO.. GSCG 60 days over DD satisfied!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150565181
https://www.otcmarkets.com/stock/LAHO/news
Some folks have low risk tolerance and sold @- $.001 to ride free shares. Some may have sold 10-20 million shares to secure $10-20k, profit lost at $.005-$.01 massive $50-200k! right strategy?
When the DD presents a golden opportunity the entry point should be Asap.
..If you could have a solid annual return on your money without using principal for withdrawals, would you take that opportunity?
https://www.forbes.com/sites/impactpartners/2019/04/01/is-your-portfolio-bulletproof/amp/
How to Say 'Yes' to Investing Risk
Eliminating risk in one area increases your exposure in another. Here's how to embrace risk instead.
..RISK IS AN INHERENT part of investing. Greater risk often brings greater reward, but that doesn't mean investors are eager to gamble.
..Avoiding stocks, and risk in general, may insulate your portfolio from seismic market shifts, but you may sacrifice growth in exchange. David A. Schneider, principal of New York-based Schneider Wealth Strategies, says investors often get risk all wrong. "Investing is about embracing risk, not avoiding it," he says, and trying to eliminate it from your investments is impossible. Each time you reduce risk in one area, you increase exposure to a different risk.
https://money.usnews.com/investing/buy-and-hold-strategy/articles/2017-11-24/how-to-say-yes-to-investing-risk
$LAHO GSCG each division is worth pennies, Combined?
$LAHO..We've brought together eight companies on the cutting edge of #healing into one global network. #stemcell
https://mobile.twitter.com/StemCellGroupUS
http://www.stemcellsgroup.com/our-story/
STEM CELL CENTER INC. TO OPEN NEW, FULL-SERVICE INDIAN CENTER
http://www.stemcellsgroup.com/open-new-full-service-indian-center/
Chapter 11 Company Profiles
Beike Biotechnology Co. Ltd.
Mesoblast Ltd.
Novartis
https://www.businesswire.com/news/home/20190815005269/en/Worldwide-Stem-Cell-Regenerative-Therapy-Markets-2018-2019
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
Venture capitalists are betting big on one area of regenerative medicine
https://amp.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Money is pouring in to a hot new area of science that could change the way we think about aging
https://amp.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
$LAHO Affluent Cash paid or financed GSCG collects, pouring money.. Printing$$..Each division GSCG could land in pennies..Combined??$$
$LAHO Lans Holdings Inc. is pleased to announce that Global Stem Cells Group Inc.
has opened two new stem cell offices, one in Valencia, Spain and one in Cochabamba, Bolivia. This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
The new clinic in Valencia will be the group’s third operation in Spain and the fourth in Europe. The Global Stem Cells Group’s Valencia center joins the already existing centers in Spain, which include locations in Bruselas, Madrid, and Barcelona. In opening the new center, GSCG has signed an agreement with Dra. Caicedo, a specialist in hair loss treatment with an interest in delivering stem cell based treatments to her patients in Valencia.
Lans Holdings is currently working to bring all of its financials current and expects this to be completed and filed with the SEC within the next 90 days.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Further information on the Company can be found at www.sec.gov and the company's website at www.LansHoldings.com.
https://www.globenewswire.com/news-release/2019/06/12/1867610/0/en/LAHO-Global-Stem-Cells-Group-Announces-Opening-of-Two-New-Stem-Cell-Centers.html
PRP AND STEM CELL TREATMENTS BEING STUDIED FOR HAIR LOSS
Adimarket helps, alongside a few other companies, to help provide new and reliable uses for PRP and stem cell therapies. We provide the equipment and other services so that doctors and practices will be able to provide these services to their patients.
..These include doctors, and practices, such as a doctor from Miami known as Lazaro M Garcia Md. This doctor already utilized PRP and stem cell therapy for people who suffer from hair loss, and is currently conducting a study that is supported by the National Institutes of Health.
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/
Hair., Market..expand..25% CAGR..USD 24.8 bn by 2024
https://www.reuters.com/brandfeatures/venture-capital/article?id=69816%C2%A0
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
..The use of stem cells has been reported to improve hair regrowth in several therapeutic strategies, including reversing the pathological mechanisms, that contribute to hair loss, regeneration of hair follicles, or creating hair using the tissue-engineering approach.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562814/
Soon There Will Be Unlimited Hair
New uses of stem cells and 3-D printing could make baldness obsolete (for the wealthy).
..The answer, then, lies in generating new hair. This science is progressing alongside the creation of other bodily structures in what is known as cell therapy, a promising area of medicine in which therapies are derived from a person’s own stem cells. Pancreatic cells could replace those that stopped producing insulin in people with type 1 diabetes. Immune cells could be used to attack tumors. Nerve cells could be used to repair spinal-cord injuries. And, of course, hair follicles could be used to cover hairless skin
..https://www.google.com/amp/s/amp.theatlantic.com/amp/article/594826/
$LAHO GSCG Each therapy sector is worth $Billions proven by science.
$LAHO Who Wants To Live Forever?..The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
$ Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Morningstar World Stem Cell Summit
..World Stem Cell Summit will take place January 21-24, 2020, in Miami, Florida. The Summit is the most inclusive and expansive interdisciplinary, networking, and partnering meeting in the stem cell science and regenerative medicine field.
https://www.morningstar.com/news/globe-newswire/7692763/inaugural-world-stem-cell-summit-china-phacilitate-leaders-asia-will-foster-understanding-and-collaborations-accelerating-regenerative-medicine
GSCG Miami!
Osiris Therapitics $118m GSCG #5
https://www.zoominfo.com/c/osiris-therapeutics-inc/38552366
http://www.annualreports.com/HostedData/AnnualReportArchive/c/NASDAQ_CLBS_2011.pdf
$LAHO Best place to park it, support of Billionaires..clubs..banking, Stem cells.
$LAHO thanks for the update my friend..
Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
Medical containers are refrigerated and pricey!
Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies to
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE..119 pages
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
N-Biotek is GSCG supplier-Distributor, magellan another Giant in Health!$$
$LAHO Mother Load, fullfill huge orders 40 footers, complete lab?Adimarket a divison if GSCG can run to multi pennies alone, combined$$$?
$LAHO..GSCG.. Adimarket announce agreement.. N-Biotek to offer the Total Solution highly manipulated stem cell culture expansion lab, complete with equipment, training, facilities, stem cell processing center, clean rooms, project plan and more- a total turnkey lab solution for emerging stem cell businesses and industry professionals.
The announcement marks a new chapter in GSCG’s ongoing expansion, and commitment to bring stem cell therapies to
..Until now, Admarket has been GSCG’s online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals, offering basic tools and products to facilitate in-office stem cell procedures. However, through N-Biotek, Adimarket now offers the Total Solution labs and all the accoutrements. From planning to building the facility, to training and consultation, Total Solution users are equipped in every way possible to walk in and begin using their fully-equipped biotechnology lab in short order.
https://www.stemcelltraining.net/total-solution/
N-Biotek History
http://www.n-biotek.com/index.php?module=Board&action=SiteBoard&iBrdNo=9&sMode=SELECT_FORM
Clinical trials news
http://www.mesenchymalcellnews.com/issue/volume-8-34-aug-30/
Product Catalog!
http://n-biotek.com/N-BIOTEK_PRODUCT_CATALOG_VOL_18.pdf
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
$LAHO N-Biotek is GSCG supplier-Distributor, magellan another Giant in Health!$$
$LAHO indeed my friend, all 9 parts of GSCG-LAHO super busy. Wonder if those containers are full Labs?
cherrs
$LAHO accumulating every week, thanks followed back!
all the best!
$LAHO Adimarket import.. 40 FOOT CONTAINER South Korea
Adimarker Llc imports from N-biotek, Inc. in South Korea through the port of Los Angeles, California
..DESCRIPTION CENTRIFUGES FOR LABORATORY USE 8421.19-1000
..SUPPLIER N-BIOTEK, INC.
https://www.importgenius.com/importers/adimarket-llc
$LAHO Mother Load, fullfill some big orders 40 footers, rest info paid for service!
$LAHO Morningstar World Stem Cell Summit
..World Stem Cell Summit will take place January 21-24, 2020, in Miami, Florida. The Summit is the most inclusive and expansive interdisciplinary, networking, and partnering meeting in the stem cell science and regenerative medicine field.
https://www.morningstar.com/news/globe-newswire/7692763/inaugural-world-stem-cell-summit-china-phacilitate-leaders-asia-will-foster-understanding-and-collaborations-accelerating-regenerative-medicine
GSCG Miami!
Osiris Therapitics $118m GSCG #5
https://www.zoominfo.com/c/osiris-therapeutics-inc/38552366
http://www.annualreports.com/HostedData/AnnualReportArchive/c/NASDAQ_CLBS_2011.pdf
Going through Caladrius Biosciences old 10k 196 pages, GSCG has all the right connects, China, Latin America, Europe, Middle east!
$LAHO Indeed my friend, patience and Opportunity$$
$LAHO Anti-aging and the billionaires young blood & stem cell club
https://ipscell.com/2018/09/anti-aging-and-the-billionaires-young-blood-stem-cell-club/
https://www.nextbigfuture.com/2018/08/80-year-old-billionaires-are-injecting-placental-stem-cells-to-boost-lifespan-and-health.html?amp
Who Wants To Live Forever?...The Super-Rich, That's Who (And Most Everyone Else)
..Not only do many of the super-rich want immortality, but a good number of them are doing something about it. The likes of Sergey Brin, co-founder of Google, Larry Ellison, Co-founder of Oracle, and investor Peter Thiel are all putting money into ventures that are focused on extending the human life span.
..Hacking our DNA is another approach being taken. Our ability to use stem cells to cure disease is becoming increasingly an opportunity. Very possibly using stem cell technology, as well as modifications to our DNA, can result in significantly longer fruitful lives.
https://www.forbes.com/sites/russalanprince/2018/01/02/who-wants-to-live-forever-the-super-rich-thats-who-and-most-everyone-else/amp/
$LAHO time and probabilities that is all. Best place to park it, support of Billionaires..clubs..banking, Stem cells.
$LAHO Folks GSCG is in a $600B industry and multi-revenue. Laho alone has blockchain, already in gear. GSCG 8 companies per division and 9 with LAHO!
Folks that own shares are fortunate to have strong support from Adimarker to professional provider network in 27 counties in 38 clinics world wide. GSCG offers Data analytics, Medical devices, Certification including training and support, marketing and 2 clinical trials. If we split each Sector into single company they would each run to multi pennies..combined?
Examples Bio-tech
DXT* Bankrupt traded 2 years at $.02
ALR* single day .02-.13
Other examples..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150565181
If we are to entertain numeric value based on how other “sole-stem cells” companies ran keep in mind we at LAHO are that much diverse, so perhaps GSCG is X> more valuable and AS has no bearing if not sold. I recall scanning recent runners from .01-.035. Of which some was hype, and or funny products i.e Solar BBQ, or single Applications both of which have limited market.
My game plan accumulate and to hold, as the more I dig into each sector of stem cells market the higher the Market Dollar Value protrudes.
How often are we given the opportunity to invest in a SC-mega runner..been years?
$LAHO GSCG Holding for Gold!
$LAHO Hair., Market..expand..25% CAGR..USD 24.8 bn by 2024
https://www.reuters.com/brandfeatures/venture-capital/article?id=69816%C2%A0
Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
..The use of stem cells has been reported to improve hair regrowth in several therapeutic strategies, including reversing the pathological mechanisms, that contribute to hair loss, regeneration of hair follicles, or creating hair using the tissue-engineering approach.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562814/
Soon There Will Be Unlimited Hair
New uses of stem cells and 3-D printing could make baldness obsolete (for the wealthy).
..The answer, then, lies in generating new hair. This science is progressing alongside the creation of other bodily structures in what is known as cell therapy, a promising area of medicine in which therapies are derived from a person’s own stem cells. Pancreatic cells could replace those that stopped producing insulin in people with type 1 diabetes. Immune cells could be used to attack tumors. Nerve cells could be used to repair spinal-cord injuries. And, of course, hair follicles could be used to cover hairless skin
..https://www.google.com/amp/s/amp.theatlantic.com/amp/article/594826/
Lans Holdings Inc. is pleased to announce that Global Stem Cells Group Inc.
has opened two new stem cell offices, one in Valencia, Spain and one in Cochabamba, Bolivia. This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
The new clinic in Valencia will be the group’s third operation in Spain and the fourth in Europe. The Global Stem Cells Group’s Valencia center joins the already existing centers in Spain, which include locations in Bruselas, Madrid, and Barcelona. In opening the new center, GSCG has signed an agreement with Dra. Caicedo, a specialist in hair loss treatment with an interest in delivering stem cell based treatments to her patients in Valencia.
Lans Holdings is currently working to bring all of its financials current and expects this to be completed and filed with the SEC within the next 90 days.
For more information on Global Stem Cells Group please visit: www.stemcellsgroup.com
Further information on the Company can be found at www.sec.gov and the company's website at www.LansHoldings.com.
https://www.globenewswire.com/news-release/2019/06/12/1867610/0/en/LAHO-Global-Stem-Cells-Group-Announces-Opening-of-Two-New-Stem-Cell-Centers.html
PRP AND STEM CELL TREATMENTS BEING STUDIED FOR HAIR LOSS
Adimarket helps, alongside a few other companies, to help provide new and reliable uses for PRP and stem cell therapies. We provide the equipment and other services so that doctors and practices will be able to provide these services to their patients.
..These include doctors, and practices, such as a doctor from Miami known as Lazaro M Garcia Md. This doctor already utilized PRP and stem cell therapy for people who suffer from hair loss, and is currently conducting a study that is supported by the National Institutes of Health.
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/
$LAHO GSCG Each therapy sector is worth $Billions proven by science.
$LAHO..Regenerative..Market..North America..largest share globally, and also grow at a faster rate during the forecast period.
The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this Regenerative Medicine Market.
https://www.ptcommunity.com/wire/stem-cell-therapy-market-1458-million-2021-exclusive-report-marketsandmarkets
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150577714
Forbes..Regenerative Medicine..Healthcare's Saving Grace?
Regenerative Medicine: Could This Be Healthcare's Saving Grace?
..Knee Replacements will be Unnecessary in the Next Five Years Cell therapy makes up over 60% of the regenerative medicine market, most of which is in the area of stem cell therapy. Adult stem cells can be used in the areas of cardiology; musculo-skeletal, including neurology; optometry; dermatology; cosmology; wound healing; and cancer. Stem cell therapy, when combined with immune and gene therapy, shows even greater potential to cure diseases.
..These international clinics are charging anywhere from $20,000 to $100,000 per treatment, and they are not covered by insurance.
https://www.forbes.com/sites/reenitadas/2015/11/06/regenerative-medicine-could-this-be-healthcares-saving-grace/#7d9e655c1049
Cell Expansion Market to Register a CAGR of 15.4% From 2019 to 2024
PUNE, India, May 14, 2019 /PRNewswire/ -- The Cell Expansion Market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period. Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities.
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo BCT (Japan), Merck KGaA (Germany), Danaher Corporation (US), MiltenyiBiotec (Germany), Lonza Group Ltd. (Switzerland), STEMCELL Technologies Inc. (Canada), GE Healthcare (US), and Corning, Inc. (US).
https://www.ptcommunity.com/wire/cell-expansion-market-register-cagr-154-2019-2024-reportsnreports
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
STEM CELL CENTER INC. TO OPEN NEW, FULL-SERVICE INDIAN CENTER
http://www.stemcellsgroup.com/open-new-full-service-indian-center/
The Stem Cell Group
@StemCellGroupUS
We've brought together eight companies on the cutting edge of #healing into one global network. #stemcell
https://mobile.twitter.com/StemCellGroupUS
http://www.stemcellsgroup.com/our-story/
$LAHO Affluent Cash paid or financed GSCG collects, BOFA Printing$$
$LAHO Hedge Fund Fights Over Stem-Cell Company's Value in Cayman Court
..claiming a proposed $915 million all-share merger would reduce the value of their holdings.
..Global Cord Blood, once known as China Cord Blood, is China’s oldest and largest company that specializes in extracting, processing and storing umbilical cord stem cells that can be used to treat diseases such as leukemia.
https://www.bloomberg.com/amp/news/articles/2019-07-29/hedge-fund-fights-over-stem-cell-company-s-value-in-cayman-court
Chapter 11 Company Profiles
Beike Biotechnology Co. Ltd.
Mesoblast Ltd.
Novartis
https://www.businesswire.com/news/home/20190815005269/en/Worldwide-Stem-Cell-Regenerative-Therapy-Markets-2018-2019
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
The Wall Street Journal – Hedge-Fund Founder Bolsters Stem-Cell Research With $27 Million Gift
https://nyscf.org/resources/the-wall-street-journal-hedge-fund-founder-bolsters-stem-cell-research-with-27-million-gift/
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
Venture capitalists are betting big on one area of regenerative medicine
https://amp.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
Money is pouring in to a hot new area of science that could change the way we think about aging
https://amp.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
$LAHO GSCG All directions head to Money$$$
$LAHO BOFA recently toured the University of Miami Miller School of Medicine Division of Neonatology
..Accompanied by Miller School and Department of Pediatrics leadership, the representatives visited the areas the bank’s donation supported: the Bank of America Molecular and Cell Biology Neonatal Research Lab, and the Schatzi and Stanley Kassal Project: New Born Neonatal Intensive Care Unit (NICU) at Holtz Children’s Hospital at the University of Miami/Jackson Memorial Medical Center.
“We are so pleased that our investment in two of Miami’s anchor organizations 10 years ago continues to yield benefits for our community,” said Gene Schaefer, Miami market president at Bank of America,
..Young’s primary research focus is bronchopulmonary dysplasia and pulmonary hypertension. She has completed all of the pre-clinical work and is hoping to launch the first-ever in-human clinical trial in the U.S. exploring the use of bone-marrow derived mesenchymal stem cells to treat bronchopulmonary dysplasia.
https://physician-news.umiamihealth.org/bank-of-america-charitable-foundation-representatives-tour-renovated-laboratory-and-nicu/amp/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150565181
Marker Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
https://www.prnewswire.com/news-releases/marker-therapeutics-to-present-at-the-bank-of-america-merrill-lynch-health-care-conference-300845554.html
Rise of Chronic Diseases Leads to Growing Investment in Stem Cell Research
https://www.prnewswire.com/news-releases/rise-of-chronic-diseases-leads-to-growing-investment-in-stem-cell-research-812068186.html
Why so many people are investing their money into stem cell research
Stem cell research has seen a boom in investment in recent years, but why exactly are large corporations just now deciding to invest their hard-earned capital in stem cell research?
Continued Innovation
Rapid Advancement
While it is always wise to approach new technology and medical advancements with measured optimism. When corporate powerhouses like Johnson & Johnson begin investing in stem cell research, it can understandably be hard to remain patient.
https://www.google.com/amp/s/www.banklesstimes.com/2019/01/23/why-so-many-people-are-investing-their-money-into-stem-cell-research/amp/
3 Companies Investing In Stem Cell Research
Novartis, Johnson & Johnson Company, Celgene Corporation
..under certain conditions in the agreement, the deal could increase to $3.3 billion.
https://finance.yahoo.com/news/3-companies-investing-stem-cell-203426117.html
$LAHO GSCG Stars Align, Bank$$$
$LAHO Rejuvenating brain stem cells may hold key to future MS treatments
https://www.medicalnewstoday.com/articles/amp/326066
Cambridge study reverses aging of key brain stem cells in rodents
https://newatlas.com/brain-stem-cells-opcs-reverse-aging-ms-cambridge/61063/
What’s next from stem cell research? Diabetes treatments and safer kidney transplants
https://geneticliteracyproject.org/2019/08/16/whats-next-from-stem-cell-research-diabetes-treatments-and-safer-kidney-transplants/
There is a rising interest in Stem Cell Therapy as a promising remedy for curing ALS. Mesenchymal stem cells are particularly believed to be the most suitable ones due to their availability, absence of ethical issues and positive results in various experiments.
Studies and clinical trials have begun to apprehend the benefits of MSC transplantation. They demonstrate that MSCs lead to a partial recovery of motor neurons and a delay in disease progression. Also, there has been no evidence of a major adverse effect after MSC transplantation.
When testing this newfound research on animals, the lifespan of the subjected animal has increased with MSC transplantation. These positive results have encouraged the administration of MSC in ALS patients.
http://www.stemcellsgroup.com/category/latest-news/
Adimarket, LLC Looks to Expand Market Reach with Launch of New PRP Product
..“Adimarket and its products have been met with great enthusiasm from physicians in the US and Latin America,” said Benito Novas, CEO of the Global Stem Cells Group
http://www.stemcellsgroup.com/adimarket-llc-looks-to-expand-market-reach-with-launch-of-new-prp-product/
$LAHO Enormous market, Therapy, Bank, Devices, Certs, Clinical Trials, Marketing..GSCG
$GBTC btc bottom in? Dec 15k?
https://www.google.com/amp/s/www.cryptonewsz.com/bitcoin-price-analysis-btc-may-surge-up-to-12000-soon/37387/amp/
glta
$LAHO HAVE A GREAT WEEKEND TO YOU AS WELL AND ALL ONBOARD AND THOSE READING!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150577714
$LAHP GSCG WILL BE REMEMBERED AS ONE OF THE GREATS!
$LAHO The Smart Money Is Piling Into Regenerative Medicine
Progressive Approval Could Be a Game Changer for RM
Investing in Regenerative Medicine
The Goldman report discusses Samumed, a private RM company. With $300 million in funding, it’s valued at a staggering $12 billion. Samumed’s drug platform aims to regenerate various tissues such as bone, cartilage, hair, and skin.
https://www.forbes.com/sites/patrickcox/2017/04/14/smart-money-is-piling-into-regenerative-medicine/#293ec5585b6c
Connections : Goldman Sachs Group Inc
New York Stem Cell Foundation, Inc.
https://www.marketscreener.com/GOLDMAN-SACHS-GROUP-INC-12831/company/
Mesoblast
Corporate Finance & Strategy
Mr Symonds was a Partner and Managing Director of Goldman Sachs Group Inc (2007-2009),
https://www.mesoblast.com/company/management-team
$LAHO Venture-capital investors.. pouring money..regenerative medicine.
Goldman Sachs defines regenerative medicine as approaches that grow cells or tissue from stem cells, treatments that promote regeneration, or transplants using organs or tissue grown outside the body.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150565181
$LAHO GSCG FUTURE OF MEDICINE, BOFA, USDHHS, GOLDMAN$$$$$
$LAHO BANK OF AMERICA FINANCING STEM
When you need financing for your OMS practice, you want to work with someone who understands your industry.
https://www.aaomsservices.org/asi-provider-services/financial-services-providers/practice-solutions-bank-of-america/
Click on bottom page PDF here is what it shows.
StemSave, Inc.*Stem cell banking from teethEnhance your practice and expand your care by providing stem cell banking services to your patients. AAOMS members enrolled in the program earn an administration fee for their assistance with each successful tooth collection. Visit StemSave.com
https://www.aaomsservices.org/wp-content/uploads/2019/02/ASI_Aug2019.pdf
$5 Million loans for Providers!
“The Moseley Foundation’s multi-year grant will spur the momentum of our cancer research program with support for a key research group investigating cancer stem cells,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute.
https://news.christianacare.org/2019/02/900k-grant-will-advance-stem-cell-research-at-the-helen-f-graham-cancer-center-research-institute/
Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference
https://www.globenewswire.com/news-release/2019/05/09/1820756/0/en/Homology-Medicines-to-Present-at-Bank-of-America-Merrill-Lynch-Health-Care-Conference.html
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150407562
$LAHO 'An ace in my pocket'
Tech elites are paying $7,000 to freeze stem cells from liposuctioned fat as a 'back up' for a longer life
Nevertheless, stem cell banking is beginning to emerge as a trend...Katakowski wouldn't share how many customers he's had so far, but said most hail from areas with tech meccas, like Silicon Valley and New York City.
https://www.businessinsider.com/stem-cell-freezing-longevity-silicon-valley-new-york-2018-9
..Successfully Completes Due Diligence..Global Stem Cells Group
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
$5M loan available for providers to start their business.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
Upcoming Events
AUG23
Certificacion en Terapias Celulares, Lima, Peru
Aug 23 - Aug 24 · 257 guests
Doctor Evolution
Get Tickets
SEP6
Certificacion en Terapias Celulares, Argentina
Sep 6 - Sep 7 · 193 guests
Ciudad Autónoma de Buenos Aires, Argentina
Get Tickets
OCT5
Conferencias sobre Terapias Celulares
Sat 8:00 AM UTC-03 · 168 guests
Santiago del Estero
Santiago del Estero, Argentina
Get Tickets
OCT12
6to Simposio Mundial de Medicina Regenerativa
Sat 9:00 AM UTC-03 · 290 guests
Hotel Panamericano Buenos Aires
Buenos Aires, Argentina
Get Tickets
OCT18
Certificacion en Terapias Celulares, Barcelona
Oct 18 - Oct 19 · 17 guests
Barcelona, Spain
Barcelona, Spain
Get Tickets
OCT24
Simposio Mundial de Medicina Regenerativa
Oct 24 - Oct 26 · 106 guests
University of Miami
Coral Gables, FL
Get Tickets
NOV1
Stem Cells Course
Nov 1 - Nov 2 · 81 guests
ISSCA
Miami Lakes, FL
Get Tickets
NOV15
Certificacion en Terapias Celulares, Mexico
Nov 15 - Nov 16 · 58 guests
https://www.facebook.com/pg/globalstemcells/events/?ref=page_internal
$LAHO GSCG ATTENDEES, CLIENTS, PROVIDERS, CUSTOMERS EVER GROWING!
$LAHO STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
For a limited time promotional shipping rates are available on most orders over $5000.
https://www.adimarket.net/how-to-order/
Our medical team adheres strictly to our inclusion and exclusion criteria.
..Patients Treatment
+2000
Improvement and satisfaction
95%
Medical cases done 5000
http://cellgenic.com/our-story/#
http://cellgenic.com/articles/
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/project-plan/
LAHO: Global Stem Cells Group Announces Opening of Two New Stem Cell Centers
..This brings the total number of global Stem Cell centers to 36 worldwide in 27 countries.
..The new clinic in Valencia will be the group's third operation in Spain and the fourth in Europe.
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
$LAHO FUTURE OF MEDICINE!
$LAHO Forbes..Regenerative Medicine..Healthcare's Saving Grace?
Regenerative Medicine: Could This Be Healthcare's Saving Grace?
..Knee Replacements will be Unnecessary in the Next Five Years Cell therapy makes up over 60% of the regenerative medicine market, most of which is in the area of stem cell therapy. Adult stem cells can be used in the areas of cardiology; musculo-skeletal, including neurology; optometry; dermatology; cosmology; wound healing; and cancer. Stem cell therapy, when combined with immune and gene therapy, shows even greater potential to cure diseases. This new combination of regenerative cell therapies will open a new age of medicine, forever changing how it is practiced. For example, in the future, knee replacements may no longer be needed with regenerative cell therapy. Regenerative medicine is not only driven by new evidence indicating these therapies are capable of curing diseases, but also by the fact that the world’s population is aging.
- CAP -1002; a leading product using cardiosphere-derived cells to treat post-myocardial infarction (heart attack), advanced heart failure, and Duchenne Muscular Dystrophy. Big Pharma Investments Big in Regeneration Medicine Big Pharma cannot be left out of this race. Many companies have become interested in regenerative medicine. Pharmaceutical companies are building relationships with innovating regenerative medicine companies. Pfizer PFE +0% Pfizer has created its own unit, Neusentis, in Massachusetts, U.S. Neusentis’ main focus is to develop cell-based therapies for age-related macular degeneration. Celgene and Teva Pharma Celgene has a 4.5% stake in Mesoblast to develop an Acute Graft Versus Host Disease (GVHD) program. Teva Pharma holds a 20% stake in Mesoblast and is a major partner in the Chronic Congestive Heart Failure (CCHF) program, in phase III clinical trials. Johnson & Johnson Johnson & Johnson invested 12.5 million in Capricor Therapeutics (CAPR) for support in a stem cell therapy program. The investment could increase to $325 million, depending on milestone attainment. The program has also received $20 million from the California Institute for Regenerative Medicine. Phase II trials for treatment of cardiovascular disease have been scheduled. The global healthcare consumer demand for stem cell therapies is very high, with stem cell therapy tourism gaining popularity - mostly from the U.S. Globally, many stem cell therapies are not clinically proven or tested, with only a few resulting in positive clinical results. These international clinics are charging anywhere from $20,000 to $100,000 per treatment, and they are not covered by insurance.
https://www.forbes.com/sites/reenitadas/2015/11/06/regenerative-medicine-could-this-be-healthcares-saving-grace/#7d9e655c1049
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
$LAHO.. affluent, are avoiding primary care and selecting regenerative care. Why not use your own stem cells to heal yourself. Nature has the cure positioned without 2 miles of the poison. Cash business, even when financed GSCG collects, Banks printing money no limits, ceiling lifted.
$LAHO Banking-wallstreet pouring investment in Stem Cells. Given the economic uncertainty and or reset, best to investment in the future of medicine.
Goldman Sachs highlighted..$12 billion private biotech startup
..Money is pouring in to a hot new area of science
ttps://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
The Stem Cell Group
@StemCellGroupUS
We've brought together eight companies on the cutting edge of #healing into one global network. #stemcell
https://mobile.twitter.com/StemCellGroupUS
http://www.stemcellsgroup.com/our-story/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
stemcelltraining
cellgenic
adimarket
Global Stem Cell Foundation
stemcellcenter
Stem Cell Symposium
http://adimarket.info/story/
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
3D Bioprinting Market To Reach USD 4.40 Billion
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
..$20 billion in mergers and acquisitions
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
Each sector of GSCG has enormous investments pouring in.
$600 Billion Market, a fraction of that market is sealed signed with GSCG$$$. Consider 2 clinical trails, Medical Devices, Stem Bank, Provider training-marketing-certification, regenerative care...Goldman and BOFA know and so does Big Pharma.
GSCG is worth far north more than a penny, it's closest competition is trading one dollar fifty two, the other is one of the largest in China.
$LAHO..RM..GSCG..$600 Billion Investments..BOFA Goldman..
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
GSCG Office $167k per year, Top Location!!!
$23.95 /SF/Yr
6,982 SF
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH.
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO..RM..Goldman Sachs BOFA Conservative $600 Billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
GSCG Office $121k per year, Top Location!!!
5274SF
$22.95 /SF/Yr
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH.
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO..GSCG RM..Stem Cells Market Conservative $600 Billion
Lans Holdings, Inc.
Our Email is:-investors@lansholdings.com
investors@lans.holdings
info@lansholdings.com
bizdev@lansholdings.com
For further information, please contact:
Telephone: +1.786.786.5758 and 305-755-7451
https://www.otcmarkets.com/stock/LAHO/disclosure
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
..(GSCG)..binding letter..to sell 100% to Lans Holdings Inc. (OTCPink: LAHO)
https://www.stemcellsgroup.com/lans-holdings-enters-into-binding-loi-to-acquire-global-stem-cells-group/
SEC filed.. penalty of $500,000 for the party that breaches terms of the binding LOI.
Lans Holdings Successfully Completes Due Diligence of Global Stem Cells Group
https://www.otcmarkets.com/stock/LAHO/news
$24.4M Zoominfo Prior Q
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
AdiMarket $10M
1 of 27 Facilities, Stem Cells Group Chile $5.6M!
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
GSCG is #1 Competitor for Biostems Tech $1.52 Dark Defunct!
GCSG is #1 competitor for Beike Biotechnology.
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG is #1 competitor Global Institute Of Stem Cell Therapy And Research!
Advisory board!
http://adimarket.info/advisory-board/
https://stemcellsgroup.cl/scg/
http://stemcellcenter.net/
GSCG TREATING FORMER NFL PRO!
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
GSCG Office $121k per year, Top Location!!!
5274SF
$22.95 /SF/Yr
A Class “A” office building
Demographics Salary $95k
https://www.loopnet.com/Listing/14750-NW-77th-Ct-Miami-Lakes-FL/6530268/
http://search.sunbiz.org/Inquiry/CorporationSearch/SearchResultDetail?inquirytype=OfficerRegisteredAgentName&directionType=Initial&searchNameOrder=NOVASBENITO%20L120000749410&aggregateId=flal-l12000074941-c51a8233-2938-4f22-b6c7-c111a2e55ddc&searchTerm=Novasanos&listNameOrder=NOVASANOS%20F120000001373
https://www.marketwatch.com/press-release/global-stem-cell-therapy-market-insight-business-evaluation-dimension-industry-grow-at-cagr-of-3652-trends-and-forecasts-2018-2023-2019-03-06
http://www.lans.holdings/
..upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Regenerative medicine..USDHHS..conservatively estimated..$500 billion by 2020
Stem cells: THE FUTURE OF MEDICINE
Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
https://medicalxpress.com/news/2017-06-stem-cells-future-medicine.amp
Regenerative medicine will dramatically alter the U.S. healthcare industry
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatmentt include:
250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually
..By doing so, we can make tissue and organ failure a relic of the past by 2020.
Interagency Federal Working Group on Regenerative Medicine
Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services
National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD
Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD
http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Global Stem..Market to Reach US$ 467 billion by 2024 ..Due to the increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
Sector Technology: 34.40
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
BioTechnology
https://www.nasdaq.com/press-release/laho-global-stem-cells-group-announces-opening-of-two-new-stem-cell-centers-20190612-00503
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG Attorney ERIC P. GROS-DUBOIS Flawless AVVO!
https://www.avvo.com/attorneys/33135-fl-eric-grosdubois-3340017.html
Eric P. Gros-Dubois, Esq.
Founding Partner
eric@epgdlaw.com
Executive Committee and Board Member of the Coral Gables Chamber of Commerce, former President of the Rotary Club of Brickell, current President of BNI Coral Gables, past president of his home owner’s association, and supporter of many fundraisers devoted to the community. Eric also regularly teaches other lawyers for their continuing legal education, presents to The American Immigration Lawyers Association, and more.
Washington College of Law. Juris Doctor (JD)
Kogod School of Business. Masters in Business Administration (MBA)
Southern Methodist University. Bachelor of Arts (BA). Sigma Chi Fraternity
Jesuit College Preparatory School, Dallas
Bar Admissions:
State of New York
State of Maryland
District of Columbia
State of Florida
Federal District Court for the Southern District of Florida
Federal District Court for Maryland
U.S. Tax Court
CLE Lecture: “The New Tax Rules for Mergers and Acquisitions.” June, 2018
https://www.epgdlaw.com/eric-p-gros-dubois/
https://www.floridabar.org/directories/find-mbr/profile/?num=83381
..Stem cells are jacks of all trades, capable of alleviating the consequences of such diverse pathologies as heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
“Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth,” says the US National Institutes of Health. “In many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive
Market cap: $2.09 billion; current share price: $24.25
Market cap: $226.15 Million; current share price: $1.83
Market cap: $161.84 million; current share price: $1.47
Market cap: $267.60 million; current share price: $19.10
Market cap: $392.71 million; current share price: $11.25
Market cap: $64.63 million; current share price: $3.43
Market cap: $54.74 million; current share price: $5.78
Market cap: $11.05 million; current share price: $0.31
Market cap: $29.88 million; current share price: $2.75
Market cap: $28.40 million; current share price: $1.30
https://investingnews.com/daily/life-science-investing/genetics-investing/top-stem-cell-nasdaq/
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
STEM CELLS CANCER TREATMENT.. COST $350,000 to $800,000.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/stem-cell-transplant/why-stem-cell-transplants-are-used.html
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs
https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives
GSCG conference in Japan..
..After receiving a personal invitation from President Susumu Takayangi MD, Global Stem Cells Group and its Korean biotechnology partner, N-Biotek, participated in the 23rd Congress of the International Society of Aesthetic Plastic Surgeons that took place this October in Kyoto.
The Congress brought together an expert panel for a series of lectures and discussions that hope to provide solutions and create new techniques in the coming years to be applied in plastic and reconstructive surgery. Influential scientific and clinical experts stood together and evaluated the state of research and clinical application.
The keynote speaker in the conference was the Nobel Laureate Shinja Yamanaka. Dr Yamanaka won the award on 2012 for his creation of induced pluripotential stem cells. Yamanaka addressed among other things the importance of the regenerative medicine field opening a new frontier for the treatment of chronic degenerative conditions.
..Both companies, as leaders of the industry, launched their new Turnkey Solution, a compact and cohesive laboratory as a concept for physicians’ offices, and the new Progenikine Kit, an enzyme based closed system for isolation of adipose derived stem cells. To learn more, visit the Global Stem Cells Group website, www.stemcellsgroup.com.
https://www.stemcelltraining.net/global-stem-cells-group-participated-expositor-23rd-congress-isaps-2016-kyoto-japan/
https://time.com/5394912/stem-cell-treatment/?amp=true
Harvard team grows cyborg mini-organs out of stem cells
https://newatlas.com/cyborg-organoids-mini-organs-sensors/61006/
Stem cells The Holy Grail Stansberry report!
..Doctors at St. Jude Children's Research Hospital used Mustang-developed "genetic surgery" to restore the broken immune systems of these eight infants afflicted with the disease. Stansberry Innovations Report editor Christian Olsen explained how this works in a private note on Friday...
First they extracted stem cells from a patient, then used a modified HIV virus to deliver and insert a healthy IL2RN gene into the stem cells, and then infused the modified stem cells back into the patient.
To get the patient ready to accept the changed cells, they were given a low dose of chemotherapy to prime the bone marrow. The bone marrow is what will produce blood cells from the genetically corrected stem cells and... Voila! Healthy immune system.
This may sound like science fiction. But it's not...
Gene therapy and editing is a real and growing trend you will hear about much more over the next several years. More from Christian...
This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.
There is no doubt we are on the cusp of more of these success stories but, remember, at this stage we (at best) have a curative potential for "bubble boy" disease. There has to be more testing, but the news is incredibly promising.
So, MBIO shot up because it's the lead dog in this treatment tech, since it licensed it to treat patients at St. Jude.
https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2
Oxford University
One of the greatest challenges of the 21st century is disease associated with ageing. Cancer, neurodegeneration and heart disease are all major causes of death and have an enormous impact on quality of life.
..Over recent years, a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon. Naturally occurring ‘immortal’ stem cells are present in all tissues of the body and act to replace loss of cells in tissues with rapid turnover, for example in the skin, blood or intestine, or to repair damage as in wound healing.
https://www.stemcells.ox.ac.uk/home
Stem Cells Are Poised to Change Health and Medicine Forever
https://www.google.com/amp/s/singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/amp/
..Our human/mouse model demonstrated that proliferating hPSC-CPCs could reduce infract size and fibrosis resulting in formation of large grafts..
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvz181/5530198
..FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.
https://www.google.com/amp/s/health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications%3fcontext=amp
..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies. The discovery of possible cardiac stem cells uncovered new arenas to repair hearts injured due to acute myocardial infarction or coronary artery disease,”
https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html
Johns Hopkins
The most successful stem cell therapy—bone marrow transplant—has been around for more than 40 years. Johns Hopkins researchers played an integral role in establishing the methods for how bone marrow transplants are done
https://www.hopkinsmedicine.org/stem_cell_research/cell_therapy/index.html
Harvard Stem Cell
..Our mission is to find cures for human diseases.
The Harvard community and the greater Boston area are home to the largest concentration of biomedical researchers in the world. This allows our network of over 1,000 scientists, from across Harvard and its eight affiliated hospitals, to advance stem cell biology and translational me
https://hsci.harvard.edu
Repairing the heart with stem cells
https://www.health.harvard.edu/heart-health/repairing-the-heart-
with-stem-cells
For a limited time promotional shipping rates are available on most orders over $ 5000 .
https://www.adimarket.net/how-to-order/
Global Stem Cells Group and Adimarket to Represent Magellan in Latin America and Middle East.
https://www.prunderground.com/global-stem-cells-group-and-adimarket-to-represent-magellan-in-latin-america-and-middle-east/00112628/
Novas’ travel took him to Dubai, Oman and Kuwait where he met with investors and learned more about medical regulations in the region.
https://www.kuam.com/story/40113402/global-stem-cells-group-visits-middle-east-in-effort-to-expand-access-to-regenerative-medicine
Global Stem Cells Group has named Aesthetic Polyclinic in Abu Dhabi, UAE, exclusive representative for GSCG in that city.
https://www.prunderground.com/global-stem-cells-group-names-aesthetic-polyclinic-exclusive-representative-in-abu-dhabi/00109409/
Adimarket, has announced an agreement with biotechnology company Alolotl Biologix
..healing for a range of conditions, including orthopedic impairments, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more.
Human allograft under FDA regulation 21 CFR Part 1271 ..Immune privileged with anti-inflammatory and anti-bacterial properties
https://www.prunderground.com/adimarket-has-announced-an-agreement-with-biotechnology-company-alolotl-biologix/00114544/
Hair Transplant Market worth over $24.8 billion by 2024:
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions in the cell and gene therapy space, or regenerative medicine, that year, according to the Alliance for Regenerative Medicine.
..FDA has "more than 800 active cell-based or directly administered gene therapy INDs on file."
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-2026-with-key-players-cord-blood-registry-cbr-systems-cordlife-group-limited-cryo-cell-international-viacord-cryo-save/
..Global Stem Cells Group Teams With CordónVida Servet Stem Cell Bank and Clinic to Organize the First International Symposium on Stem Cells and Regenerative Medicine
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.
Global Stem Cells Group, Inc. Announces Collaboration with VidaCel Laboratories and Stem Cell Bank, Chile..
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
https://www.prweb.com/releases/globalstemcellsgroup/chilesymposium/prweb11902998.htm
GSCG ISSCA Launch Dates.
•Santiago de Chile, Chile: September 5, 2019
•Bogota, Colombia: October 4, 2019
•Buenos Aires, Argentina: October 11, 2019
•Miami, Florida (in English): November 1, 2019
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149621212
..GSCG Knee Osteoarthrithis, Mayo Clinic Stem cell arthritis!
Mayo Clinic uses stem cell therapy to treat arthritis in knee
http://medprofvideos.mayoclinic.org/videos/mayo-clinic-uses-stem-cell-therapy-to-treat-arthritis-in-knee
Studies a U.S. FDA-regulated Device Product: YES
Estimated Study Start Date : May 13, 2019
Estimated Primary Completion Date : September 15, 2020
Estimated Study Completion Date : November 1, 2020
https://clinicaltrials.gov/ct2/show/NCT03752827
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
Nearly a decade of stem cell therapy experience
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
The cell is the minimal body’s representation, it is the basic unit for the living species where all the vital functions happen such as respiration, nutrition, and reproduction.
The STEM CELL is a special cell that normally circulates in the body, responsible for regenerating naturally the deteriorating organs. This treatment seeks for the stem cells to differentiate or become healthy cells from damaged or defective tissue to improve the function of the diseased organ.
http://cellgenic.com/
Cellgenic Catalogue!
$2100.00* · Brand: ADIMarket
Cellgenic Pure contains 10 millions of live nucleated cells that exert an anti inflammatory and immunomodulatory effect that aids in optimizing
$2,382.00 Cellgenic Amniotic Fluid-Human placental Derived
https://www.adimarket.net/product/cellgenic-pure-pro-cord-blood-derived/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
CELLGENIC
http://cellgenic.com
https://www.adimarket.net/product/cellgenic-pure-cord-blood-derived/
Exosomes are currently non-reactive and FDA approved.
ADIMARKET..Flow uses exosomes in compliance with US regulations to provide innovative treatment options to those suffering from degenerative diseases.
..Exosomes provide an exciting new treatment option for those suffering from degenerative diseases.
https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise
LAHO!..CEO Announces..New Stem Cell Center in Valencia, Spain
..“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1376239
NASA and Techshot Trying To 3D Print Organs In Space
https://www.nasa.gov/mission_pages/station/research/news/spx18-research
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
....“Our objective is to bring this cutting-edge3D bioprinting technology to scientists and regenerative medicine researcher..
https://www.facebook.com/pg/globalstemcells/photos/?ref=page_internal
LAHO CEO Dave Christensen highly skilled.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
..ISSCA Set to Host Regenerative Medicine Symposium in Buenos Aires
https://www.stemcellsgroup.com/
Adimarket featured products!
Magellan PRP The Magellan® technology
32” Portable Clean Room $4,500.00
INKREDIBLE 3D BIOPRINTER
BEAR C2202 Centrifuge $3,000.00
Shockwave Machine $3,500.00
H.I.F.U High Intensity Focused Ultrasound $7,500.00
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149417821
https://www.adimarket.net/product-category/in-office-processing-equipment/
Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
Global Stem Cells Group’s Benito Novas Announces Agreement with Clinica Planas
..The ongoing partnership will offer certification in regenerative medicine for European-based medical practitioners .
https://www.stemcellsgroup.com/benito-novas-announces-agreement-with-clinica-
https://cursocelulasmadre.com/entrenamiento-en-
http://www.stemcellsgroup.com/adimarket-launches-website/
..Bioheart, Inc. (otcqb:BHRT), a biotech company focused on the discovery, development and commercialization of autologous cell therapies, has announced that it has initiated a new clinical site in collaboration with Global Stem Cell Group in Cozumel, Mexico. The two companies have successfully treated their first congestive heart failure patient at the new clinical site last week using Bioheart's AdipoCell (adipose derived stem cells).
https://www.marketwatch.com/press-release/bioheart-announces-new-clinical-site-in-mexico-2013-11-25
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
Global Stem Cells Group's Chile Facility Expected to Receive Regenetech RTA Certification
https://www.newswire.com/news/global-stem-cells-groups-chile-facility-expected-to-receive-regenetech-rta
Global Stem Cells Group to Host Stem Cells and Regenerative ...
ISSCA Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols..
https://www.issca.us/stem-cells-and-regenerative-medicine-conference-in-miami/
“We are pleased to be able to open the doors on a new Stem Cells Center in Europe,” noted Novas. “The GSCG is continually exploring opportunities to deliver new stem-cell based treatment options to patients across Europe, and the Valencia center gives us the opportunity to do this while meeting our strategic mission to expand our presence in Europe.”
In opening the new center, the GSCG has signed an agreement with Dra. Laura Maria Caicedo, medical director of the Instituto Valenciano MEDEC (https://medec.es/conoce-medec/#equipoMedico). Dr. Caicedo is a specialist on hair loss with an interest in delivering stem cell based treatments to her patients and others in Valencia.
https://medec.es/conoce-medec/#equipoMedico
http://www.stemcellsgroup.com
Barcelona, Spain
J. Victor Garcia Gimenez, M.D. is president of Therapeutic Confrontations (CONFTERA), is a specialist in orthopedic surgery and practices cosmetic medicine and surgery, anti-aging medicine, and aesthetic therapies in Barcelona, Spain.
http://stemcellcenter.net/centers/spain/barcelona/barcelona-spain/\
Aesthetic Marketing Group Announces the First International Meeting on Marketing in Aesthetic Medicine
https://www.prunderground.com/aesthetic-marketing-group-announces-the-first-international-meeting-on-marketing-in-aesthetic-medicine/00124178/
GSCG..ISSCA Reaches Agreement with Belgium’s Churchill Aesthetic Center
..The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and...
Friday, June 21st 2019, 12:32 PM CDT
The innovative new center will provide training in regenerative medicine for doctors located in Belgium and France.
..We look forward to ISSCA’s exciting new partnership with Belgium’s Churchill Aesthetic Center and the possibilities it brings in delivering safe and effective regenerative medicine treatment options to more patients across the globe,” said Benito Novas, CEO of the Global Stem Cells Group.
https://www.newschannelnebraska.com/story/40691664/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center
https://www.churchill-aesthetic-center.be/autres-specialites/
....The cutting-edge facility will be equipped by Adimarket, LLC, a subsidiary of the Global Stem Cells Group. Adimarket will outfit the center with equipment and supplies designed to not only teach doctors about the latest protocols in regenerative medicine but also to treat patients suffering from degenerative diseases and sports injuries. Physicians training at the facility will have access to the proven expertise of ISSCA’s global network and training protocols.
http://www.stemcellsgroup.com/issca-reaches-agreement-with-belgiums-churchill-aesthetic-center/
Daeyong Kim, Ph.D. is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment. N-Biotek is a leader of stem cell technologies, providing solutions for providers worldwide.
..Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA
..Al Sears, M.D. often referred to as "America’s #1 anti-aging doctor," is the director of the world renowned Sears Institute for Anti-aging Medicine. Dr. Sears has published 35 books and reports on health and wellness, and has millions of loyal readers in 163 countries. Dr. Sears has been featured on ABC News, CNN and ESPN. He was one of the first specialists to be board-certified by the American Academy of Anti-Aging Medicine (A4M).
Dr. Feinerman offers stem cell treatments for a variety of disorders and diseases. He earned his medical degree from New York Medical College in 1954. Dr. Feinerman is affiliated with Long Island College Hospital in New York and Mayo Clinic in Rochester, Minnesota.
Dr. Feinerman is a member of the Society of Apheresis, Society of Bone Marrow Blood Transplantation, and the International Society for Cellular Therapy, the Society for Cranial Transplantation and Brain Repair and the Society for Cardiac Translational Therapy.
http://www.stemcellsgroup.com/advisory-board/
Global Stem Cells Group to Break Ground on New Lab in Mexico
..In addition to producing neonatal tissue derived products, the lab will also facilitate clinical trials
https://www.abc-7.com/story/40883161/global-stem-cells-group-to-break-ground-on-new-lab-in-
Bogota. August 8,9th
http://cursocelulasmadre.com/entrenamiento-en-bogota/
Buenos Aires. September 6.7th
http://cursocelulasmadre.com/entrenamiento-en-argentina/
Barcelona. October 18.19th
http://cursocelulasmadre.com/entrenamiento-en-barcelona/
Miami. November 1.2nd.
https://www.stemcelltraining.net/miami-stem-cells-course-a…/
Mexico November 15,16th
http://cursocelulasmadre.com/entrenamiento-cancun-mail/
https://www.facebook.com/globalstemcells/
Stem Data - The First Clinical Record of Regenerative Medicine in the Cloud.
http://stemdata.org
LAB FACILITY AND EQUIPMENT
http://stemcellslab.net/facility-and-equipment/
JAPAN IN PROGRESS
http://stemcellslab.net/project-plan/
GSCG Provider Testimonials
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150433068
BUSINESS OPPORTUNITY
State-Of-The-Art Equipment
We’ll set you up with the best equipment you need to process stem cells and carry out the regenerative procedures for your patients..
http://stemcellslab.net/facility-and-equipment/
http://stemcellcenter.net/programs/
$LAHO GSCG..REPRESENTING 46% MARKET GROWTH IN THERAPY REGENERATION, 3D PRINTING, COSMETIC, MEDICAL DEVICES, PROVIDER CONSULTATION. BOFA ESTIMATES $600 BILLION TARGET, USDHHS CONSERVATIVE ESTIMATE $500 billion AND IMPRESSIVE 7300% VENTURE CAPITAL INVESTMENT GROWTH.
QUOD ERAT DEMONSTRANDUM GLTA
$LAHO Global Stem Cells Group CEO Benito Novas is driven by his passion for helping physicians and scientists change the world through stem cell medicine. Dedicated to creating critical organizational systems that ensure success, he is an expert in the field of specialized marketing focused on Biotechnology, Life Sciences, and Healthcare development.
http://www.stemcellsgroup.com/management/
We’re positioning Adimarket to become the largest e-commerce marketplace for all things regenerative medicine,”,” says Benito Novas, founder and CEO of Global Stem Cells Group.
http://www.stemcellsgroup.com/adimarket-launches-website/
The Stem Cell Group
@StemCellGroupUS
We've brought together eight companies on the cutting edge of #healing into one global network.
https://mobile.twitter.com/StemCellGroupUS
http://www.stemcellsgroup.com/our-story/
https://www.issca.us/mission/
Stem Cells: The Future Looks Bright
https://www.reviewofophthalmology.com/article/stem-cells-the-future-looks-bright
Stem Cells Are Poised to Change Health and Medicine Forever
..Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
We are at the cusp of a stem cell revolution.
Recent Stem Cell Success Stories
a) Stem Cells Able to Grow New Human Eyes:
b) Stem Cell Injections Help Stroke Victims Walk Again:
c) Stem Cells Help Paralyzed Victim Gain Use of Arms:
In Conclusion
As humans, we’ve just come to accept the notion that we are going to die. However, the keys to our longevity and health may lie in our source code.
In the next two decades, stem cells are going to change medicine forever, extend life, and potentially save your life.
We truly live during the most exciting time ever in human history.
https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/
$LAHO GSCG 8 Companies Global Network
$LAHO Big Pharma..snowballing interest ..regenerative medicine.
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
GSCG..Niamed Authorized Distributor of GMTN Exosome Injection and Other Biological Products..
Scientists believe that stem cell research can be used to treat medical conditions including Parkinson's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis and rheumatoid arthritis.
http://www.stemcellsgroup.com/global-stem-cells-group-named-authorized-distributor-of-gmtn-exosome-injection-and-other-biological-products/
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
Advancells ties up with Global Stem Cells Group
https://ehealth.eletsonline.com/2015/03/advancells-ties-global-stem-cells-group/amp/
Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance
https://www.streetinsider.com/dr/news.php?id=11539116
GSCG..preparing to launch Progenikine™..
https://www.stemcelltraining.net/tag/stem-cells/page/6/
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
https://www.globenewswire.com/news-release/2019/05/02/1815536/0/en/3D-Bioprinting-Market-To-Reach-USD-4-40-Billion-By-2026-Reports-And-Data.html
NASA STEM CELLS from Space Could Help Mend Broken Hearts
https://www.nasa.gov/mission_pages/station/research/news/stem_cells_broken_hearts
$LAHO GSCG
$LAHO Forget..401(k)..Stem Cell Benefits May Let You Cheat Death
As MyCrypto mulled what benefits to offer employees, the new blockchain startup asked them what they wanted.
..A stem cell storage company that promises the chance for a longer and healthier life, Forever Labs asserts that young,
..“There’s not much downside to banking your own biology.”
https://www.bloomberg.com/news/articles/2018-08-27/companies-offer-employees-hope-with-stem-cell-storage-benefits
Dave Christiansen at Nasdaq 25years’experience in strategy deployment..
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149320841
Why Big Pharma Is Diving Into Gene Therapy
Big Pharma has been struggling for years to produce drugs that are major breakthroughs in medicine. For these companies, gene therapy may be the promised land.
Gene therapy—treatments designed to replace faulty genes with healthy ones—offers potential cures for hundreds of genetic diseases, like hemophilia and muscular dystrophy.
https://www.barrons.com/articles/why-big-pharma-is-diving-into-gene-therapy-51551493752
China Is Getting Ready to Take On the World’s Biggest Drugmakers
..BeiGene is now worth about $9 billion on the Nasdaq..Chinese companies like BeiGene are hoping to grab a bigger slice of that pie from global drugmakers, who have for years dominated local sales of innovative therapies.
..Beijing’s ‘Made in China 2025’ initiative, intended to upgrade the country’s manufacturing industries, highlights plans to develop new targeted therapies, antibodies and vaccines while working toward breakthroughs in areas like stem cells.
https://www.bloomberg.com/news/features/2018-06-19/china-s-getting-ready-to-take-on-the-world-s-biggest-drugmakers
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG Advisory Board Ming Zhang Jie, MD
http://www.stemcellsgroup.com/advisory-board/
$LAHO GSCG Largest global network$$
$LAHO GSCG..Top 3 Reasons We Offer Doctors Marketing Services
Here at Adimarket, we sell equipment to practices that are willing and able to add PRP and stem cell therapies to their lineup. The equipment we offer is among the best, and we have helped hundreds of doctors and practices to offer PRP and stem cell therapies. However, we also provide marketing services above that as well.
Regenerative Medicine Was Founded Not Too Long Ago
Compared to many other medical practices, such as surgery and physical therapy, regenerative medicine is still fairly new. In fact, most people do not really know that PRP and stem cell therapy even exists, let alone can be used to manage chronic pain.
Marketing Is Like Dieting
Pretty much every doctor and dietitian knows that good nutrition is vital to great health down the line. Waiting until you’re sick and deficient to discuss nutrition is not the best way to address the issue. Marketing is similar in that instance. Marketing not only can be used to keep current patients informed, but can also be used to inform new patients about what you offer. Practices that don’t market often suffer in the same way as people who don’t get good nutrition.
There’s a lot of competition
Medicine has sadly become more and more like a business in the past years. This means that even doctors and practices need to have a good business sense if they are going to continue to be able to provide the type of services that patients need and desire. Not understanding business would only make any practice fail or at least prevent them from growing.
Because of this, private practices, as well as other medical groups are forced to compete. Marketing is a big way to make sure that you get patients instead of your competition. If you are utilizing PRP and stem cell therapies as a way to generate more income, then great! However, you will still have to market those services to get the word out, as well as compete.
http://stemcellcenter.net/top-3-reasons-offer-doctors-marketing-services/
https://m.facebook.com/globalstemcells/posts/?ref=page_internal&refsrc=http%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx&_rdr
Stem cells could be used to grow back teeth, scientists believe
..Dr Bing Hu, who led the research said: “Stem cells are so important, as, in the future, they could be used by laboratories to regenerate tissues that have been damaged or lost due to disease - so it's vital to understand how they work.
https://www.telegraph.co.uk/science/2019/08/09/stem-cells-could-used-grow-back-teeth-scientists-believe/amp/
In the next two decades, stem cells are going to change medicine forever, extend life, and potentially save your life.
We truly live during the most exciting time ever in human history.
https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/
$LAHO Harnessing Science and Technology$$$
$LAHO Last year MJ..Future and now Stem Cells!
Stem Cells: The Future Looks Bright
https://www.reviewofophthalmology.com/article/stem-cells-the-future-looks-bright
Scientists' stem cell breakthrough ends ethical dilemma
..In a breakthrough that could have huge implications, British and Canadian scientists have found a way of reprogramming skin cells taken from adults, effectively winding the clock back on the cells until they were in an embryonic form.
https://www.theguardian.com/science/2009/mar/01/stem-cells-breakthrough
Stem Cells Are Poised to Change Health and Medicine Forever
..Over the last decade, the number of publications per year on stem cell-related research has increased 40x.
We are at the cusp of a stem cell revolution.
Recent Stem Cell Success Stories
a) Stem Cells Able to Grow New Human Eyes:
b) Stem Cell Injections Help Stroke Victims Walk Again:
c) Stem Cells Help Paralyzed Victim Gain Use of Arms:
In Conclusion
As humans, we’ve just come to accept the notion that we are going to die.
However, the keys to our longevity and health may lie in our source code.
In the next two decades, stem cells are going to change medicine forever, extend life, and potentially save your life.
We truly live during the most exciting time ever in human history.
https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/
https://www.issca.us/mission/
$LAHO GSCG NO BETTER PLACE!!
$LAHO..Goldman Sachs $12B, BOFA $600B,USDHHS $500, Bayer & PFIZER combined $161B..
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
GSCG TREATING FORMER NFL PRO!
https://www.facebook.com/pg/globalstemcells/posts/?ref=page_internal
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150549473
..engaged Fruci & Associates as its auditors as it moves forward to complete its audits and reviews of its financials to bring the company back to current status.
https://www.otcmarkets.com/stock/LAHO/news/story?e&id=1404069
Stem cells: THE FUTURE OF MEDICINE
..Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..
singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html
$600 BILLION BOFA..WALL STREET'S MAJOR INVESTMENT BANKS..
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
.. This is a massive deal and will position the newly combined company as the largest pharmaceutical company in the world, bumping out current leader, Switzerland’s Novartis AG, for 1st place.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
..Stem Cell Center, Inc. is the world's largest collective support & advisory network of regenerative medicine clinics and and physicians
http://stemcellcenter.net/
ADMIMARKET BIOTECHNOLOGY BIOMEDICAL EQUIPMENT CATALOGUE 119 pages
https://2nvdue1pi3s51uaik42s7kgz-wpengine.netdna-ssl.com/wp-content/uploads/2017/05/ADIMarket_1.pdf
$LAHO GSCG MARKET HAS SPOKEN FOR FUTURE OF MEDICINE.
$LAHO Goldman Sachs highlighted..$12 billion private biotech startup that wants to regenerate hair, skin, bones, and joints, and Unity Biotechnology, which is working on treatments that act on senescent cells.
Money is pouring in to a hot new area of science that could change the way we think about aging
.."We believe companies backed by academic pioneers ... or those with novel platforms ... are likely to garner the largest investments and valuations," the report said.
https://www.businessinsider.com/venture-capital-interest-in-regenerative-medicine-2017-4
https://www.goldmansachs.com/insights/pages/from_briefings_10-dec-2018.html
Venture capitalists..betting big on..regenerative medicine
..Until the myth of the fountain of youth proves true, regenerative medicine is the best hope we’ve got for fixing failed body parts and, as a result, living longer.
..scientists seek funding from public sources too, of course. At the University of Washington’s Institute for Stem Cell and Regenerative Medicine, for example, researchers are manipulating stem cells to heal and restore the function in hearts, eyes, kidneys and other tissues,
https://qz.com/954673/venture-capitalists-are-betting-big-on-one-area-of-regenerative-medicine/
Researchers Discover Stem Cells..for Growing and Healing Bone
..“This is the first direct evidence that bone contains multiple populations of stem cells with different functions and anatomic locations,” Dr. Greenblatt said. “Until now, drug discovery has involved looking at a mixed bag of stem cells from inside and outside bone. We believe that many therapies that build bone to treat osteoporosis may work by activating these periosteal stem cells. Working directly with this exact cell type will be essential for developing new targeted drugs for osteoporosis and healing bone injuries.”
https://news.weill.cornell.edu/news/2018/10/researchers-discover-stem-cells-responsible-for-growing-and-healing-bone
Chasing a Cure for Lung Disease With Stem Cells: A Conversation With Finn Hawkins
..It was proof of concept that if you could perform gene editing on patients with this mutation, it would be enough to cure the disease.
https://www.bmc.org/healthcity/research/chasing-cure-lung-disease-stem-cells
Cord blood stem cells: worth the investment
https://www.nature.com/articles/nrc2418-c2.pdf?origin=ppub
GSCG PRP and stem cell treatments being studied for hair loss
http://www.stemcellsgroup.com/prp-stem-cell-treatments-studied-hair-loss/
Hair Transplant Market worth over $24.8 billion by 2024: Global Market Insights, Inc.
https://www.globenewswire.com/news-release/2018/08/14/1551331/0/en/Hair-Transplant-Market-worth-over-24-8-billion-by-2024-Global-Market-Insights-Inc.html
The injection of PRP is a procedure and therefore not regulated by the US Food and Drug Administration (FDA). The FDA has approved multiple devices used to separate whole blood into PRP through the 510(k) process.
https://www.medscape.com/viewarticle/734499_3
https://www.fda.gov/media/101263/download
..global stem cell therapy..average growth rate of 46.8%
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150541611
$LAHO MONEY MAKING INDUSTRY BACKED BY SCIENCE.
$LAHO Why Big Pharma Is Diving Into Gene Therapy
Big Pharma has been struggling for years to produce drugs that are major breakthroughs in medicine. For these companies, gene therapy may be the promised land.
Gene therapy—treatments designed to replace faulty genes with healthy ones—offers potential cures for hundreds of genetic diseases, like hemophilia and muscular dystrophy.
https://www.barrons.com/articles/why-big-pharma-is-diving-into-gene-therapy-51551493752
Welcome to the Age of One-Shot Miracle Cures That Can Cost Millions
Gene therapy appears to successfully treat once-incurable patients like “bubble boy” Omarion Jordan. But progress like this doesn’t come cheap.
https://www.bloomberg.com/news/features/2019-06-05/gene-therapy-appears-to-be-beating-once-incurable-diseases
Forget the 401(k), Stem Cell Benefits May Let You Cheat Death
As MyCrypto mulled what benefits to offer employees, the new blockchain startup asked them what they wanted.
..A stem cell storage company that promises the chance for a longer and healthier life, Forever Labs asserts that young,
..“There’s not much downside to banking your own biology.”
https://www.bloomberg.com/news/articles/2018-08-27/companies-offer-employees-hope-with-stem-cell-storage-benefits
China Is Getting Ready to Take On the World’s Biggest Drugmakers
..BeiGene is now worth about $9 billion on the Nasdaq..Chinese companies like BeiGene are hoping to grab a bigger slice of that pie from global drugmakers, who have for years dominated local sales of innovative therapies.
..Beijing’s ‘Made in China 2025’ initiative, intended to upgrade the country’s manufacturing industries, highlights plans to develop new targeted therapies, antibodies and vaccines while working toward breakthroughs in areas like stem cells.
https://www.bloomberg.com/news/features/2018-06-19/china-s-getting-ready-to-take-on-the-world-s-biggest-drugmakers
Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.
https://beikebiotech.com
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.
..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.
ZhangM3
..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...
https://www.ncbi.nlm.nih.gov/pubmed/28353401
GSCG Advisory Board Ming Zhang Jie, MD
http://www.stemcellsgroup.com/advisory-board/
$LAHO GSCG FUTURE OF MEDICINE$$$
$LAHO..5000 cases, 2 Clinical trials, 37 clinics GLOBAL!
Patients Treatment +2000
Improvement and satisfaction 95%
Medical cases done 5000
http://cellgenic.com/our-story/#
http://cellgenic.com/articles/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150429125
The Shiller P/E is a more reasonable market valuation indicator than the P/E ratio because it eliminates fluctuation of the ratio caused by the variation of profit margins during business cycles.
Sector Healthcare: 30.50
https://www.gurufocus.com/shiller-PE.php
http://www.econ.yale.edu/~shiller/
1. STEM BANK
2. THERAPY
3. MEDICAL DEVICES
4. CERTS TRAINING
5. LAB
6. STEMDATA
7. CLINICAL TRIALS
8. ACQUISITION BY BIG PHARMA
9. EXPANSION CRITERIA
EACH SECTOR ABOVE IS UNIQUE AND CANNOT BE MEASURED BY STANDARD P/E ETC.. WHY?
Amag Pharma..buy world's largest stem..bank..$700 million
..and that it was on the hunt for more deals.
..Advisors
Deutsche Bank and Jefferies LLC served as financial advisors to AMAG on the transaction. AMAG's legal advisor is Goodwin Procter LLP. CBR's and GTCR's legal advisor is Kirkland & Ellis LLP. Jefferies Finance LLC and Barclays are serving as initial lenders and lead arrangers for the committed debt financing, and Jones Day served as their legal advisor.
https://www.globenewswire.com/news-release/2015/06/29/748090/10139996/en/AMAG-Pharmaceuticals-to-Acquire-Cord-Blood-Registry.html
..One of the biggest investment opportunities over the next decade will be in companies working to delay human death, a market expected to be worth at least $600 billion by 2025..
https://www.worldstemcellsummit.com/2019/05/09/human-lifespan-could-soon-pass-100-years-thanks-to-medical-tech-says-bank-of-america/
Pfizer and Allergan Merge in $160 Billion Deal to Become New Behemoth in the Drug World
What Does Pfizer Have to do with the World of Stem Cells?
Most people would not call Pfizer a stem cell company, much less a cell therapy company, a regenerative medicine company, or even a biotech company. Pfizer is viewed as a “classic and traditional” pharmaceutical company, best known for its blockbuster sales of drugs, such as Lipitor and Viagra. While Pfizer is largely a drug company, the company has expressed periodic interest in the stem cell sector.
https://bioinformant.com/pfizer-and-allergan-merge-in-160-billion-deal-to-become-new-behemoth-in-the-drug-world/amp/
PFIZER ACQUIRES A STEM-CELL THERAPY
But as the science of stem cells has advanced, drug companies are taking an interest.
http://www.stem-cells-news.com/1/pfizer-acquires-a-stem-cell-therapy/
GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China
Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration from 1995 to 2013 in various research positions including National Research Center (NRC) senior associate..
....In 2013, Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.
http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/
$LAHO MULTI-REVENUE STREAM GOLDEN COMPANY!
$LAHO..global stem cell therapy..average growth rate of 46.81%
Stem Cell Therapy Market Segment by Applications, can be divided into:
Musculoskeletal Disorder
Wounds and Injuries
Cornea
Cardiovascular Diseases
Others
https://www.marketwatch.com/press-release/stem-cell-therapy-market-2019-global-industry-trends-statistics-competition-strategies-revenue-analysis-key-players-regional-analysis-by-forecast-to-2024-2019-06-27
Harvard Stem Cell
..Our mission is to find cures for human diseases.
https://hsci.harvard.edu/
Yale
The potential impact of stem cell research on human health is enormous.
https://medicine.yale.edu/stemcell/people/research/therapy.aspx
https://medicine.yale.edu/news/medicineatyale/a-shangrila-for-stem-cell-research-at-yale.aspx
YALE
Stem cells..jacks of all trades. alleviating..heart attacks, strokes and cancer.
..In a new study, Yale researchers succeeded in doing so, opening the door to new stem cell-inspired, cell-free treatments for the effects of a heart attack.
https://phys.org/news/2019-07-decoding-cells-stem-potential.html
OXFORD
a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.
https://www.stemcells.ox.ac.uk/home
upsurge in venture capital investment..growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Adimarket 119 pages Medical devices!
CONSUMER REPORT..stem cells market. a whole lot of demand
https://consumerreportsreview.com/stem-cells-market-is-likely-to-exhibit-a-strong-13-80-cagr-between-2017-and-2025/
Stem..Market.Growth..Due to.. increased funding from Government and Private sector and rising global awareness.
https://www.marketwatch.com/press-release/global-stem-cells-market-is-determined-to-reach-us-467-billion-by-2024-2019-03-05
Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-centre, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis.
https://biovaultfamily.com/health-hub/musculoskeletal-conditions/global-stem-cells-group-plans-bone-marrow-clinical-trials-for-knee-osteoarthritis/
https://www.prunderground.com/global-stem-cells-group-takes-part-in-clinical-trial/00150836/
$LAHO $600B market..20M shares @.05 $1M!..Conservative measure...FACTS CONTROL THE NARRATIVE<<<.
$LAHO..”GSCG Teams With CordónVida Servet Stem Cell Bank and Clinic”
..,Latin America’s oldest and largest cryopreserved umbilical cord cell bank.
http://stemcellcenter.net/global-stem-cells-group-inc-announces-collaboration-with-vidacel-laboratories-and-stem-cell-bank-chile/
..Stem Cell Banking Market to Witness Astonishing Growth
https://www.aglobalmarketresearch.com/stem-cell-banking-market-to-witness-astonishing-growth-of-10-cagr-by-
Medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering.
https://www.sciencedaily.com/terms/stem_cell_treatments.htm
Global Stem Cells Group to Break Ground on New Lab in Mexico
..the new lab will fill a much-needed research and production niche in the regenerative medicine field and will be especially beneficial to physicians practicing in Latin America and the United States.
All tissue will come from local donors, with the lab strictly adhering to donor ethics and the FDA’s approved serological screening policies.
http://www.stemcellsgroup.com/the-new-stem-cells-lab-is-set-to-break-ground-in-2020-providing-affordable-regenerative-medicine-products-to-latin-america-and-the-us/
$LAHO STEM BANK ONE ASPECT OF GSCG MARKET!!